Long-term follow-up of the effectiveness of one whole-cell and two acellular pertussis vaccines based on a randomised controlled vaccine trial in Sweden
Acta Paediatr
.
2022 May;111(5):1052-1053.
doi: 10.1111/apa.16184.
Epub 2021 Dec 10.
Authors
Bernice Aronsson
1
,
Emma Appelqvist
1
,
Kerstin Jämtberg
1
,
Henrik Källberg
1
,
Patrick Olin
1
,
Jann Storsaeter
1
Affiliation
1
The Public Health Agency of Sweden, Solna, Sweden.
PMID:
34773298
DOI:
10.1111/apa.16184
No abstract available
Publication types
Randomized Controlled Trial
MeSH terms
Follow-Up Studies
Humans
Infant
Pertussis Vaccine*
Sweden
Whooping Cough* / prevention & control
Substances
Pertussis Vaccine
Grants and funding
GlaxoSmithKline
Sanofi